- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT01770028
Ripple Effect of Lifestyle Intervention During Pregnancy on Partners' Weight
8 februari 2018 uppdaterad av: Todd Hagobian, California Polytechnic State University-San Luis Obispo
The primary aim of the proposed study is to determine whether lifestyle interventions to prevent excessive gestational weight gain in overweight/obese pregnant women have positive "ripple" effects on untreated partners in the home.
We hypothesize that partners of pregnant women randomized to the lifestyle intervention, relative to those of standard care, will have greater weight losses through 12-months.
Secondary aims examine partner improvements in weight control behaviors, the home environment, and psychosocial parameters.
Studieöversikt
Status
Avslutad
Betingelser
Detaljerad beskrivning
Lifestyle interventions targeting overweight individuals can produce positive "ripple" effects on untreated overweight partners in the home.
Interestingly, ripple effects on partners' weight appear most pronounced when the interventions target women.
Women, and mothers in particular, remain the primary "nutritional gatekeepers" of the home.
Despite widespread recognition that motherhood is a powerful motivator for behavior changes, no study to date has examined the "ripple" effects of prenatal lifestyle interventions that target mothers' gestational weight gain.
The primary aim of the proposed study is to determine whether lifestyle interventions to prevent excessive gestational weight gain in overweight/obese pregnant women have positive "ripple" effects on untreated partners in the home.
The proposed study is ancillary to two randomized phase III clinical trials in the LIFE-moms consortium (1U01HL114377-01, PI Phelan; 3U01DK094463-03S1, PIs Pi-Sunyer and Gallagher) that are examining the efficacy of multi-component lifestyle interventions to prevent excessive gestational weight gain in a total of 650 overweight/obese women.
In this ancillary study, partners' weight, home environment, and psychosocial behaviors will be assessed when their pregnant partners are ~13 weeks gestation (study entry), 35 weeks gestation and at 6 and 12 months postpartum.
We hypothesize that partners of pregnant women randomized to the lifestyle intervention, relative to those of standard care, will have greater weight losses through 12-months.
Secondary aims examine partner improvements in weight control behaviors, the home environment, and psychosocial parameters.
This project is highly innovative, as it capitalizes on existing funded research and is the first study to examine ripple effects of multicomponent prenatal interventions.
The project also has high impact, as pregnancy is a powerful motivator for behavior and environmental changes in the home; and, if positive ripple effects occur, the field of obesity treatment and prevention could move beyond focus on individual level to the often unrecognized interpersonal effects of lifestyle interventions.
PUBLIC HEALTH RELEVANCE: This research project will examine whether interventions to prevent excessive gestational weight gain have positive "ripple" effects on the health of untreated partners in the home.
Studietyp
Observationell
Inskrivning (Faktisk)
122
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
California
-
San Luis Obispo, California, Förenta staterna, 93407
- California Polytechnic State University
-
-
New York
-
New York, New York, Förenta staterna, 10027
- Columbia University
-
-
Rhode Island
-
Providence, Rhode Island, Förenta staterna, 02906
- Miriam Hospital
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
18 år och äldre (Vuxen, Äldre vuxen)
Tar emot friska volontärer
Ja
Kön som är behöriga för studier
Allt
Testmetod
Icke-sannolikhetsprov
Studera befolkning
This study uses a randomized repeated measures design.
Partners will be categorized based on randomized status of their pregnant partner (in the parent grants; NIH 1U01HL114377-01, PI Phelan; NIH 3U01DK094418-01S1, PIs Redman and Martin).
Partner participation in the ancillary study will not be mandatory for participation in the parent grant.
NOTE: There is no intervention in partners.
Beskrivning
Inclusion Criteria:
- Man or woman who self-identifies as sharing an intimate relationship and cohabitating in the home with the pregnant women (enrolled in the parent grant) for the previous 3 months or recently been married and living in the home
- ≥18 years
- willing to provide informed consent/assent
Exclusion Criteria:
- None
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
Kohorter och interventioner
Grupp / Kohort |
|---|
|
Intervention partners
Partners of pregnant women randomized to lifestyle intervention.
Note: There is no intervention in partners of pregnant women.
|
|
Standard care partners
Partners of pregnant women randomized to Standard Care.
Note: There is no intervention in partners of pregnant women.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change in weight of partners of pregnant women
Tidsram: 13 weeks gestation, 35 weeks gestation, 6 months and 12 months postpartum
|
Change in weight of partners of pregnant women randomized to the lifestyle intervention, relative to partners of pregnant women of standard care, from 13 weeks gestation to 35 weeks gestation and 6 and 12-months postpartum.
|
13 weeks gestation, 35 weeks gestation, 6 months and 12 months postpartum
|
Sekundära resultatmått
Resultatmått |
Tidsram |
|---|---|
|
Percent of partners with weight change loss >5%, 10%, and 15%
Tidsram: 13 weeks gestation, 35 weeks gestation, 6 months and 12 months postpartum
|
13 weeks gestation, 35 weeks gestation, 6 months and 12 months postpartum
|
|
Change in calorie and fat intake
Tidsram: 13 weeks gestation, 35 weeks gestation, 6 months and 12 months postpartum
|
13 weeks gestation, 35 weeks gestation, 6 months and 12 months postpartum
|
|
Change in physical activity levels
Tidsram: 13 weeks gestation, 35 weeks gestation, 6 months and 12 months postpartum
|
13 weeks gestation, 35 weeks gestation, 6 months and 12 months postpartum
|
|
Change in sleep patterns and sleep hours
Tidsram: 13 weeks gestation, 35 weeks gestation, 6 months and 12 months postpartum
|
13 weeks gestation, 35 weeks gestation, 6 months and 12 months postpartum
|
|
Change in self-monitoring
Tidsram: 13 weeks gestation, 35 weeks gestation, 6 months and 12 months postpartum
|
13 weeks gestation, 35 weeks gestation, 6 months and 12 months postpartum
|
|
Change in food, exercise and sedentary cues in the home environment
Tidsram: 13 weeks gestation, 35 weeks gestation, 6 months and 12 months postpartum
|
13 weeks gestation, 35 weeks gestation, 6 months and 12 months postpartum
|
|
Change in mood
Tidsram: 13 weeks gestation, 35 weeks gestation, 6 months and 12 months postpartum
|
13 weeks gestation, 35 weeks gestation, 6 months and 12 months postpartum
|
|
Change in dietary restraint
Tidsram: 13 weeks gestation, 35 weeks gestation, 6 months and 12 months postpartum
|
13 weeks gestation, 35 weeks gestation, 6 months and 12 months postpartum
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Utredare
- Huvudutredare: Todd A Hagobian, PhD, California Polytechnic State University-San Luis Obispo
Publikationer och användbara länkar
Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart
1 januari 2013
Primärt slutförande (Faktisk)
1 juli 2017
Avslutad studie (Faktisk)
1 juli 2017
Studieregistreringsdatum
Först inskickad
8 januari 2013
Först inskickad som uppfyllde QC-kriterierna
15 januari 2013
Första postat (Uppskatta)
17 januari 2013
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
12 februari 2018
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
8 februari 2018
Senast verifierad
1 februari 2018
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 1R01HL118208 (U.S.S. NIH-anslag/kontrakt)
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .